Form 4: Albemarle CCO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Albemarle Corporation's Chief Commercial Officer, Eric Norris, reported the sale of 5,692 shares of common stock at $165.45 per share, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Eric Norris, Chief Commercial Officer of Albemarle Corporation (ALB), reported a sale of common stock.
- The transaction involved the disposition of 5,692 shares of common stock.
- The shares were sold at a price of $165.45 per share.
- The transaction date was February 20, 2026.
- The sale was conducted under a Rule 10b5-1(c) pre-arranged trading plan.
- Following the transaction, Eric Norris beneficially owns 48,819 shares of Albemarle common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. Insider sales, especially under a 10b5-1 plan, are routine disclosures and do not typically indicate a change in company fundamentals or management's long-term outlook.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are common and often pre-scheduled through 10b5-1 plans to avoid accusations of trading on material non-public information. This filing is a routine disclosure for a public company executive.
Comparison to Industry Standards
- This is a standard Form 4 filing for an insider transaction, which is a routine compliance disclosure across all publicly traded companies. There are no specific comparable companies, projects, or results mentioned in the filing itself to compare against.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance Mechanism Update | Eric W. Norris granted a Power of Attorney to designated individuals (Ander Krupa, Rebekah Richards, Amanda Miljenovic, Brenda Mareski) to prepare, execute, and submit SEC filings (Forms 3, 4, 5, etc.) on his behalf, and to manage his EDGAR account. | 06/05/2025 | Enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions. |
Stakeholder Impact
- Shareholders: Minor, as it is a routine insider sale under a pre-arranged plan and does not typically signal a change in company fundamentals.
- Employees, Customers, Suppliers, Creditors: No direct impact from this routine insider transaction.
Key Dates
| Date | Description |
|---|---|
| 06/05/2025 | Date Power of Attorney was executed by Eric W. Norris. |
| 02/20/2026 | Date of common stock transaction (sale of 5,692 shares). |
| 02/23/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe reported insider sale by Eric Norris is a routine transaction executed under a pre-arranged 10b5-1 trading plan. Such transactions are common for executives and generally do not reflect a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter the investment thesis.
Keywords
Albemarle, ALB, Eric Norris, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Chief Commercial Officer, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.